kenji

Astellas confirms Kenji Yasukawa as new President and CEO

February 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, appointment

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …

arcturus_joseph-e-payne

CEO gets the axe: Arcturus relieve Payne of position

February 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical

Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …

J&J’s apalutamide shows strength in non-metastatic prostate cancer

February 7, 2018
Research and Development J&J, JJ, Johnson & Johnson, pharma, prostate cancer

Johnson & Johnson unveiled new data at the ASCO Genitourinary Cancer symposium which demonstrated that its androgen receptor antagonist apalutamide …

array_biopharma

Array’s melanoma therapy blasts Roche’s out of water

February 7, 2018
Research and Development Array Biopharma, Pierre Fabre, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

Array Biopharma suffered a serious knock back in early 2017 when its plan to commercialise its drug, binimetinib, were derailed …

allergan

Allergan bolsters skincare portfolio with Elastagen acquisition for $95 million

February 7, 2018
Research and Development, Sales and Marketing Allergan, Elastagen, M&A, MA, pharma

Pharma’s M&A train keeps on going as news breaks that Allergan has picked up University of Sydney spin-off Elastagen for …

flu

NHS tells doctors to order stronger vaccine for next winter

February 7, 2018
Medical Communications, Research and Development NHS, biotech, drugs, flu season, pharma, pharmaceutical

England is not alone in being particularly hard hit this flu season, with Australia suffering its worst flu season in …

allergan-westport-ireland_web

New breakthrough for CGRP migraine treatments

February 6, 2018
Research and Development Allergan, Amgen, CGRP, Novartis, biotech, drugs, pharma, pharmaceutical

Allergan had a rough year in 2017, dropping by close to $80 a share from February 2017 to this month. …

mark_walsh_allergan

Allergan successfully concludes CFO search

February 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

Allergan has been searching for a new Chief Financial Officer since Tessa Hilado, its current CFO, revealed that she would …

450px-papilloma_virus_hpv

UK Government to offer HPV vaccine to men who have sex with men

February 6, 2018
Manufacturing and Production, Medical Communications, Research and Development England, HPV, UK, human papillomavirus, pharma, vaccination

The UK Government has confirmed a national vaccination programme that will provide access for men who have sex with men(MSM) …

radio-active-2003201_960_720

PTx picks up radiation drug and plant from Sanofi

February 6, 2018
Manufacturing and Production, Sales and Marketing Partnership Therapeutics, Sanofi, biotech, drugs, pharma, pharmaceutical

A Boston-based biotech, only a few weeks old, has moved quickly to secure both the drug Leukine and the plant …

BMS’ Opdivo and Yervoy combo better than chemo in halting lung cancer progression

February 6, 2018
Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, NSCLC, Yervoy, lung cancer, opdivo, pharma

Bristol-Myers Squibb has revealed promising data from its ongoing Phase 3 study investigating the efficacy of Opdivo (nivolumab) in combination …

abbottweb

Abbott teams up with Angle for metastatic breast cancer study

February 6, 2018
Manufacturing and Production, Research and Development Abbott, Angle, Cancer, breast cancer, pharma

Abbott is set to join forces with liquid biopsy medtech firm Angle to collaborate on a study into metastatic breast …

Two former Greek PMs implicated in Novartis bribery case

February 6, 2018
Manufacturing and Production, Medical Communications Greece, Novartis, biotech, drugs, pharma, pharmaceutical

An ongoing investigated case into Novartis sales practices in Greece has so far implicated 10 current and former politicians. The …

ai_graphic

The future is now: The transformative power of AI

February 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …

nektar-therapeutics

Rapidly-growing Nektar Therapeutics reportedly considering sale of its business

February 5, 2018
Manufacturing and Production, Sales and Marketing M&A, MA, Nektar, Nektar Therapeutics, acquisition, pharma

After a slew of M&A deals throughout the first month of 2018, including Celgene’s buyout of Juno Therapeutics for $9 …

shutterstock_158366573

UK GPs are “undervalued” with 40% looking to quit profession, study finds

February 5, 2018
Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma

Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in …

pink_ribbon

UK breast cancer mortality falls 10% over five years, overtaken by prostate deaths for first time

February 5, 2018
Research and Development, Sales and Marketing Cancer, Cancer Research UK, breast cancer, pharma, prostate cancer

Breast cancer deaths in the UK have fallen by 10% in the past five years, according to research released by …

Philippines’ launches legal action after Sanofi refuses to refund over dengue vaccine damages

February 5, 2018
Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

Sanofi has refused both requests from the Government of the Philippines to refund used doses of its Dengvaxia vaccine as …

india-coor-locator

64% of FDC antibiotics in India are unapproved, report reveals

February 5, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, India, antimicrobial resistance, pharma

The majority of fixed dose combination (FDC) antibiotics that are made and sold in India are still unapproved, despite promises …

The Gateway to Local Adoption Series

Latest content